Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J I ROBERTSON

Showing results (111-120 of 175) with videos related to

Pageof 18
Sort By:
Gut|April 1, 1971
An unusual case of self-induced electrolyte depletionD R Love, J J Brown, R Fraser, et al.
Clinical Endocrinology|August 1, 1977
Amiloride in the treatment of primary hyperaldosteronism and essential hypertensionD Kremer, K Boddy, J J Brown, et al.
British Journal of Clinical Pharmacology|June 1, 1982
Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressureA B Atkinson, A M Cumming, J J Brown, et al.
Lancet (London, England)|June 5, 1976
Mechanism of renal hypertensionJ J Brown, D L Davies, J J Morton, et al.
British Journal of Clinical Pharmacology|March 1, 1984
Effect of the 5-hydroxytryptamine type 2 receptor antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympatho-adrenal function in patients with essential hypertensionJ R Zabludowski, C Zoccali, C G Isles, et al.
British Journal of Clinical Pharmacology|March 1, 1982
Response of the renin-angiotensin-aldosterone system to upright tilting and to intravenous frusemide: effect of prior metoprolol and propranololS Sonkodi, E Agabiti-Rosei, R Fraser, et al.
Journal of Human Hypertension|June 1, 1987
Severe hypertension with absent secondary sex characteristics due to partial deficiency of steroid 17 alpha-hydroxylase activityR Fraser, J J Brown, P A Mason, et al.
British Journal of Clinical Pharmacology|September 1, 1983
The effect of a 5-HT antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympathoadrenal function in normal manC Zoccali, J R Zabludowski, C G Isles, et al.
Journal of Cardiovascular Pharmacology|July 1, 1986
Captopril in heart failure: a double-blind study of the effects on renal functionJ G Cleland, H J Dargie, G Gillen, et al.
Lancet (London, England)|September 22, 1979
Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captoprilA B Atkinson, D L Davies, B Leckie, et al.
Pageof 18

Showing results (111-120 of 175) with videos related to

Sort By:
Pageof 18
Gut|April 1, 1971
An unusual case of self-induced electrolyte depletionD R Love, J J Brown, R Fraser, et al.
Clinical Endocrinology|August 1, 1977
Amiloride in the treatment of primary hyperaldosteronism and essential hypertensionD Kremer, K Boddy, J J Brown, et al.
British Journal of Clinical Pharmacology|June 1, 1982
Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressureA B Atkinson, A M Cumming, J J Brown, et al.
Lancet (London, England)|June 5, 1976
Mechanism of renal hypertensionJ J Brown, D L Davies, J J Morton, et al.
British Journal of Clinical Pharmacology|March 1, 1984
Effect of the 5-hydroxytryptamine type 2 receptor antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympatho-adrenal function in patients with essential hypertensionJ R Zabludowski, C Zoccali, C G Isles, et al.
British Journal of Clinical Pharmacology|March 1, 1982
Response of the renin-angiotensin-aldosterone system to upright tilting and to intravenous frusemide: effect of prior metoprolol and propranololS Sonkodi, E Agabiti-Rosei, R Fraser, et al.
Journal of Human Hypertension|June 1, 1987
Severe hypertension with absent secondary sex characteristics due to partial deficiency of steroid 17 alpha-hydroxylase activityR Fraser, J J Brown, P A Mason, et al.
British Journal of Clinical Pharmacology|September 1, 1983
The effect of a 5-HT antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympathoadrenal function in normal manC Zoccali, J R Zabludowski, C G Isles, et al.
Journal of Cardiovascular Pharmacology|July 1, 1986
Captopril in heart failure: a double-blind study of the effects on renal functionJ G Cleland, H J Dargie, G Gillen, et al.
Lancet (London, England)|September 22, 1979
Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captoprilA B Atkinson, D L Davies, B Leckie, et al.
Pageof 18